Literature DB >> 16611250

Polymorphism in the proximal promoter region of the perforin gene and its impact on the course of HIV infection.

D McIlroy1, L Meyer, Y Dudoit, A Samri, J-F Delfraissy, B Autran, P Debré, I Theodorou.   

Abstract

Cytotoxic T lymphocytes (CTLs) play an essential role in the control of viral replication during human immunodeficiency virus (HIV) infection. However, the efficacy of the CTL response varies between individuals. We tested the hypothesis that genetic polymorphisms in the lytic effector molecule perforin could influence the progression of HIV infection. The perforin gene was screened for single nucleotide polymorphisms (SNPs) by denaturing high-performance liquid chromatography (dHPLC). Correlations were sought between perforin genotype, perforin expression and lytic function of CD8+ T lymphocytes from HIV-positive patients. Association of perforin genotype with disease progression was investigated in 426 seroconverters enrolled in the French SEROCO cohort. AIDS-free survival curves were constructed using the Kaplan-Meier method and compared using the log-rank test. Three SNPs were found in the proximal promoter region of the perforin gene: 63G (allelic frequency 0.029), 112G (allelic frequency 0.071) and 1012T (allelic frequency 0.070). The presence of the 1012T genotype correlated with fewer perforin+ cells among circulating CD8+ CTL. However, CTL lines from HIV(-positive) individuals heterozygous for the perforin 1012T SNP displayed normal lysis of target cells, and within the SEROCO cohort, patients heterozygous for the 1012T SNP showed normal disease progression. However, 1012T/T homozygotes showed a tendency towards slower disease progression (P = 0.08). In conclusion, polymorphism in the perforin gene is limited, and although the 1012T genotype appears to influence perforin expression, it was not conclusively associated with disease progression in HIV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611250     DOI: 10.1111/j.1744-313X.2006.00571.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  4 in total

1.  Analysis of the -398C/T polymorphism in the perforin gene in oncohematological patients.

Authors:  Fernanda Bernadelli Garcia; Rafaella Kizzy Inácio Dos Reis; Lucas Emanuel Pinheiro da Silva; Helio Moraes-Souza
Journal:  Rev Bras Hematol Hemoter       Date:  2011

Review 2.  Host factors influencing susceptibility to HIV infection and AIDS progression.

Authors:  Juan Lama; Vicente Planelles
Journal:  Retrovirology       Date:  2007-07-25       Impact factor: 4.602

3.  Perforin gene PRF1 c.900C> T polymorphism and HIV-1 vertical transmission.

Authors:  Luisa Zupin; Vania Polesello; Anselmo Jiro Kamada; Rossella Gratton; Ludovica Segat; Louise Kuhn; Sergio Crovella
Journal:  Genet Mol Biol       Date:  2019-11-14       Impact factor: 1.771

4.  Perforin and hematological cancer.

Authors:  Dimas Tadeu Covas
Journal:  Rev Bras Hematol Hemoter       Date:  2011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.